ASNDAscendis Pharma A/S

ASND Stock Price, Valuation & Chart | Ascendis Pharma A/S

Compare

$225.25-1.37 (-0.60%)

At close · 16 Oct 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology

Overview Financials Dividends Ratios

ASND Historical price chart

ASND Key Stats

Market Capitalization14.05B

PE Ratio-93.08

EPS-2.42

Trading Volume680.31K

Today's High/Low227.03/223.54

Dividend Yield0.00

52 Week High/Low282.15/186.05

Shares Outstanding62.38M

ASND Financial Statement

ASND Analyst ratings

ASND Analysis & performance metrics

ASND Company profile

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth…

Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult hypoparathyroidism; and TransCon CNP for…

ASND Management team

Name

Position

Flemming Steen Jensen

Executive Vice President of Product Supply & Quality

Jan Moller MikkelsenCEO

President, Chief Executive Officer, Member of Executive Board & Executive Director

Scott T. SmithCFO

Chief Financial Officer, Executive Vice President & Member of Executive Board

Pedersen Anni Lotte Kirstine Sonderbjerg

Executive Vice President, Chief Administrative Officer & Member of the Executive Board

Michael Wolff Jensen L.L.M.

Executive Vice President, Chief Legal Officer & Member of the Executive Board

Kennett Sprogoe Ph.D.

Executive Vice President and Head of Research & Product Development

Stina Singel M.D., Ph.D.

Executive Vice President & Head of Clinical Development for Oncology

Sherrie Glass

Chief Business Officer

Name

Position

Flemming Steen Jensen

Executive Vice President of Product Supply & Quality

Jan Moller MikkelsenCEO

President, Chief Executive Officer, Member of Executive Board & Executive Director

Scott T. SmithCFO

Chief Financial Officer, Executive Vice President & Member of Executive Board

Pedersen Anni Lotte Kirstine Sonderbjerg

Executive Vice President, Chief Administrative Officer & Member of the Executive Board

Michael Wolff Jensen L.L.M.

Executive Vice President, Chief Legal Officer & Member of the Executive Board

Kennett Sprogoe Ph.D.

Executive Vice President and Head of Research & Product Development

Stina Singel M.D., Ph.D.

Executive Vice President & Head of Clinical Development for Oncology

Sherrie Glass

Chief Business Officer

Management Team

Flemming Steen Jensen

Executive Vice President of Product Supply & Quality

Jan Moller MikkelsenCEO

President, Chief Executive Officer, Member of Executive Board & Executive Director

Scott T. SmithCFO

Chief Financial Officer, Executive Vice President & Member of Executive Board

Pedersen Anni Lotte Kirstine Sonderbjerg

Executive Vice President, Chief Administrative Officer & Member of the Executive Board

Michael Wolff Jensen L.L.M.

Executive Vice President, Chief Legal Officer & Member of the Executive Board

Kennett Sprogoe Ph.D.

Executive Vice President and Head of Research & Product Development

Stina Singel M.D., Ph.D.

Executive Vice President & Head of Clinical Development for Oncology

Sherrie Glass

Chief Business Officer

Management

Flemming Steen Jensen

Executive Vice President of Product Supply & Quality

Jan Moller MikkelsenCEO

President, Chief Executive Officer, Member of Executive Board & Executive Director

Scott T. SmithCFO

Chief Financial Officer, Executive Vice President & Member of Executive Board

Pedersen Anni Lotte Kirstine Sonderbjerg

Executive Vice President, Chief Administrative Officer & Member of the Executive Board

Michael Wolff Jensen L.L.M.

Executive Vice President, Chief Legal Officer & Member of the Executive Board

Kennett Sprogoe Ph.D.

Executive Vice President and Head of Research & Product Development

Stina Singel M.D., Ph.D.

Executive Vice President & Head of Clinical Development for Oncology

Sherrie Glass

Chief Business Officer

Total 8 executives

ASND Frequently asked questions

What is Ascendis Pharma A/S (ASND) Stock Price?

Current stock price of Ascendis Pharma A/S (ASND) stock is $225.25. The stock price is -0.60% lower in the session. The intraday range can be seen from this page. Volume of Ascendis Pharma A/S (ASND) stock is 680.31K.

Last updated at 16 Oct 2026, 08:00 pm.

Why is the Ascendis Pharma A/S (ASND) stock price going up or down today?

The stock price of Ascendis Pharma A/S (ASND) can change with earnings, company news, and overall market sentiment. Ascendis Pharma A/S operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Ascendis Pharma A/S stock expensive at its current price?

Whether Ascendis Pharma A/S looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ASND on this page is -93.08. EPS on this page is -2.42. Compare those figures with peers and growth expectations before deciding if the current Ascendis Pharma A/S price is justified.

How has the stock price of Ascendis Pharma A/S (ASND) performed historically?

Historical performance for Ascendis Pharma A/S (ASND) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ASND reacted to past earnings and market events.

Should I buy Ascendis Pharma A/S (ASND) stock, at this price?

Buying Ascendis Pharma A/S (ASND) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.